Suppr超能文献

考科蓝专刊:新型冠状病毒感染的普遍筛查。

Cochrane corner: universal screening for SARS-CoV-2 infection.

机构信息

Cochrane South Africa, South African Medical Research Council, Cape Town, South Africa.

Communicable Disease Control, Department of Health, Western Cape, South Africa.

出版信息

Pan Afr Med J. 2020 Dec 16;37(Suppl 1):48. doi: 10.11604/pamj.supp.2020.37.48.26881. eCollection 2020.

Abstract

INTRODUCTION

coronavirus disease 2019 (COVID-19) is caused by the novel coronavirus, severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). Most people infected with SARS-CoV-2 have mild disease with non-specific symptoms, although a few becoming critically ill with septic shock and multiple organ failure. There is an unknown proportion of infected individuals who remain asymptomatic and infectious. Universal screening for COVID-19 infections to detect individuals who are infected before they present clinically could therefore be an important measure to contain the spread of the disease. We highlight a Cochrane rapid review which assessed the effectiveness and accuracy of universal screening for COVID-19 infection.

METHODS

the authors of the Cochrane review searched multiple electronic databases to identify studies reporting on the effectiveness of universal screening and reporting on screening test accuracy. Eligible participants for the review included people who had not sought care for potential COVID-19 symptoms.

RESULTS

the authors included 22 publications, with none of them conducted in Africa. Two modelling studies reported on the beneficial and negative effects of screening; and 20 studies (cohort and modelling) reported data on the accuracy of screening tests. The included studies had wide variability in the baseline prevalence of COVID-19 infection as well as study settings and methods. All cohort studies compared screening strategies to reverse transcriptase-polymerase chain reaction (RT-PCR) as the gold standard. The rapid review suggests that there is low certainty of evidence that screening at travel hubs may slow the importation of infected cases. Furthermore, the review highlights the uncertainty and variation in the accuracy of screening.

CONCLUSION

given the low accuracy of the tests included in this review, a high proportion of COVID-19 infected individuals may be missed and go on to infect others. In addition, some healthy individuals may be falsely identified as positive, requiring confirmatory testing and potentially leading to the unnecessary isolation of these individuals.

摘要

简介

新型冠状病毒病(COVID-19)由新型冠状病毒,即严重急性呼吸综合征冠状病毒-2(SARS-CoV-2)引起。大多数感染 SARS-CoV-2 的人患有轻度疾病,症状不具特异性,尽管少数人会发展为感染性休克和多器官衰竭的重症患者。还有一部分感染个体无症状且具有传染性,未知比例。对 COVID-19 感染进行普遍筛查,以发现临床前感染的个体,因此可能是控制疾病传播的重要措施。我们强调了 Cochrane 快速评价,该评价评估了对 COVID-19 感染进行普遍筛查的效果和准确性。

方法

Cochrane 评价的作者检索了多个电子数据库,以确定报告普遍筛查效果和报告筛查检测准确性的研究。该评价的合格参与者包括未因潜在 COVID-19 症状而寻求治疗的人。

结果

作者纳入了 22 篇出版物,没有一篇在非洲进行。两项建模研究报告了筛查的有益和负面影响;20 项研究(队列和建模)报告了筛查检测准确性的数据。纳入的研究在 COVID-19 感染的基线患病率以及研究环境和方法方面存在很大差异。所有队列研究都将筛查策略与逆转录-聚合酶链反应(RT-PCR)作为金标准进行了比较。快速评价表明,有低确定性证据表明,在旅行枢纽进行筛查可能会减缓感染病例的输入。此外,该评价强调了筛查准确性的不确定性和差异。

结论

鉴于本评价中包含的检测方法准确性较低,可能会错过大量 COVID-19 感染个体,并继续感染其他人。此外,一些健康个体可能被错误地识别为阳性,需要进行确认性检测,并且可能导致这些个体不必要的隔离。

相似文献

1
Cochrane corner: universal screening for SARS-CoV-2 infection.
Pan Afr Med J. 2020 Dec 16;37(Suppl 1):48. doi: 10.11604/pamj.supp.2020.37.48.26881. eCollection 2020.
2
Universal screening for SARS-CoV-2 infection: a rapid review.
Cochrane Database Syst Rev. 2020 Sep 15;9(9):CD013718. doi: 10.1002/14651858.CD013718.
5
Cochrane corner: rapid point-of-care antigen and molecular-based tests for the diagnosis of COVID-19 infection.
Pan Afr Med J. 2020 Sep 15;37(Suppl 1):10. doi: 10.11604/pamj.supp.2020.37.10.25982. eCollection 2020.
6
Thoracic imaging tests for the diagnosis of COVID-19.
Cochrane Database Syst Rev. 2020 Sep 30;9:CD013639. doi: 10.1002/14651858.CD013639.pub2.
8
Comparison of molecular testing strategies for COVID-19 control: a mathematical modelling study.
Lancet Infect Dis. 2020 Dec;20(12):1381-1389. doi: 10.1016/S1473-3099(20)30630-7. Epub 2020 Aug 18.
9
Systematic screening on admission for SARS-CoV-2 to detect asymptomatic infections.
Antimicrob Resist Infect Control. 2021 Feb 27;10(1):44. doi: 10.1186/s13756-021-00912-z.

引用本文的文献

2
Impact of Mass Workplace COVID-19 Rapid Testing on Health and Healthcare Resource Savings.
Int J Environ Res Public Health. 2021 Jul 3;18(13):7129. doi: 10.3390/ijerph18137129.
3
A Cost-Benefit Analysis of the COVID-19 Asymptomatic Mass Testing Strategy in the North Metropolitan Area of Barcelona.
Int J Environ Res Public Health. 2021 Jun 30;18(13):7028. doi: 10.3390/ijerph18137028.

本文引用的文献

1
Universal screening for SARS-CoV-2 infection: a rapid review.
Cochrane Database Syst Rev. 2020 Sep 15;9(9):CD013718. doi: 10.1002/14651858.CD013718.
2
Detection of imported COVID-19 cases worldwide: early assessment of airport entry screening, 24 January until 17 February 2020.
Trop Med Health. 2020 Sep 14;48:79. doi: 10.1186/s41182-020-00260-5. eCollection 2020.
4
Universal screening for the SARS-CoV-2 virus on hospital admission in an area with low COVID-19 prevalence.
Infect Control Hosp Epidemiol. 2020 Oct;41(10):1231-1233. doi: 10.1017/ice.2020.358. Epub 2020 Jul 23.
5
Universal screening for SARS-CoV-2 before labor admission during Covid-19 pandemic in Madrid.
J Perinat Med. 2020 Nov 26;48(9):981-984. doi: 10.1515/jpm-2020-0236.
6
COVID 19: Should we consider universal screening in trauma patients?
Injury. 2020 Aug;51(8):1942. doi: 10.1016/j.injury.2020.06.013. Epub 2020 Jun 15.
7
The prospects for the SARS-CoV-2 pandemic in Africa.
EMBO Mol Med. 2020 Jun 8;12(6):e12488. doi: 10.15252/emmm.202012488. Epub 2020 May 5.
8
Effectiveness of airport screening at detecting travellers infected with novel coronavirus (2019-nCoV).
Euro Surveill. 2020 Feb;25(5). doi: 10.2807/1560-7917.ES.2020.25.5.2000080.
10
Entry screening to delay local transmission of 2009 pandemic influenza A (H1N1).
BMC Infect Dis. 2010 Mar 30;10:82. doi: 10.1186/1471-2334-10-82.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验